Results 71 to 80 of about 914,390 (333)

Assessing a Mitochondrial Disease Treatment via a Novel Statistical Technique for Accelerometer Data

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Therapeutic development for mitochondrial diseases, rare genetic disorders with pathogenic defects of oxidative phosphorylation, is hindered by unsatisfactory outcome measures. To address this problem, we provide the first clinical application of a novel, bias‐adjusted outcome measure of acceleration across a range of subjects ...
Ian W. McKeague   +8 more
wiley   +1 more source

Доказана генетическая предрасположенность к хронической боли

open access: yesМедицинский совет, 2014
Обнаружены гены, определяющие чувствительность человека к хронической боли, сообщает Medical News Today по материалам ежегодной конференции Американской академии неврологии в Филадельфии.
Editorial Article
doaj   +1 more source

CYPminer: an automated cytochrome P450 identification, classification, and data analysis tool for genome data sets across kingdoms

open access: yesBMC Bioinformatics, 2020
Background Cytochrome P450 monooxygenases (termed CYPs or P450s) are hemoproteins ubiquitously found across all kingdoms, playing a central role in intracellular metabolism, especially in metabolism of drugs and xenobiotics.
Ohgew Kweon   +12 more
doaj   +1 more source

Ethical Issues in the Drug Approval Process [PDF]

open access: yes, 2013
The Food and Drug Administration’s (FDA) drug approval process carries great significance for both pharmaceutical companies and for patients. In recent decades, there has been a shift towards expedited approval so that drugs, especially those for ...
McInnis, Meghan
core   +1 more source

Fate and effect of antibiotics in beef and dairy manure during static and turned composting [PDF]

open access: yes, 2017
Manure composting has general benefits for production of soil amendment, but the effects of composting on antibiotic persistence and effects of antibiotics on the composting process are not well-characterized, especially for antibiotics commonly used in ...
FDA   +14 more
core   +1 more source

Where, how, and how much? A multicenter cohort study of the relationship between lupus decision aid modality, place of administration, interruption and viewing completeness and patient‐reported outcomes

open access: yesArthritis Care &Research, Accepted Article.
Objective We assessed whether shared decision‐making (SDM), and patient acceptability, feasibility, and overall satisfaction with a computerized patient decision aid (PtDA) for patients with systemic lupus erythematosus (SLE), differs by PtDA setting, modality, and the viewing experience.
Jasvinder A. Singh   +3 more
wiley   +1 more source

Regulatory controls for direct-to-consumer genetic tests: a case study on how the FDA exercised its authority

open access: yesNew Genetics and Society, 2017
In February 2015, 23andMe received clearance from the United States Food and Drug Administration (FDA) for a carrier status test for a gene linked to Bloom syndrome.
Margaret Curnutte
doaj   +1 more source

В целом пациенты удовлетворены лечением послеоперационных болей

open access: yesМедицинский совет, 2014
Пациенты, принимающие непосредственное участие в принятии решений, связанных с лечением послеоперационных болей, в большей степени удовлетворены проводимой терапией.
Editorial Article
doaj   +1 more source

Nudging the FDA [PDF]

open access: yes, 2014
[Excerpt] The FDA’s regulation of drugs is frequently the subject of policy debate, with arguments falling into two camps. On the one hand, a libertarian view of patients and the health care system holds high the value of consumer choice.
Cohen, I. Glenn, Price, W. Nicholson, II
core   +1 more source

Global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis burden, 1990–2021

open access: yesArthritis Care &Research, Accepted Article.
Objective This study examined the global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis (OA) burden from 1990 to 2021. Methods Age‐standardized years lived with disability rate for site‐specific OA across 204 countries/territories were obtained from the Global Burden of Diseases Study (GBD) 2021.
Haowei Chen   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy